Actinogen Medical Limited (ATGGF)
OTCMKTS · Delayed Price · Currency is USD
0.0250
0.00 (0.00%)
Oct 13, 2025, 8:00 PM EDT
Actinogen Medical Market Cap
Actinogen Medical has a market cap or net worth of $59.69 million as of October 15, 2025. Its market cap has increased by 18.45% in one year.
Market Cap
59.69M
Enterprise Value
51.11M
Revenue
3.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since October 16, 2007, Actinogen Medical's market cap has increased from 11.50M to 59.69M, an increase of 419.13%. That is a compound annual growth rate of 9.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 59.69M | 23.16% |
| Dec 31, 2024 | 48.47M | 40.08% |
| Dec 29, 2023 | 34.60M | -71.81% |
| Dec 30, 2022 | 122.77M | -40.54% |
| Dec 31, 2021 | 206.48M | 778.52% |
| Dec 31, 2020 | 23.50M | -16.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 694.90M |
| Elite Pharmaceuticals | 673.15M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 334.34M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 259.79M |